Skip to content

Geriatric Oncology Care in Brazil: Remote Geriatric Assessment-Driven Interventions With Supportive Care

Geriatric Oncology Care in Brazil: Remote Geriatric Assessment-Driven Interventions With Supportive Care (The GAIN-S Trial in Brazil)

Status
Enrolling by invitation
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07084454
Acronym
GAIN-S
Enrollment
350
Registered
2025-07-24
Start date
2024-12-06
Completion date
2028-11-30
Last updated
2025-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Activities of Daily Living, Aging, Depression, Functional Decline, Geriatric Assessment, Geriatric Oncology, Quality of Life, Supportive Care in Cancer

Keywords

Geriatric Assessment, Geriatric Oncology, Older Adults with Cancer, Multidisciplinary Intervention, CARG-GA, Telehealth, Functional Status, Depression, Quality of Life, Brazil, Randomized Controlled Trial, Remote Care Delivery

Brief summary

The goal of this clinical trial is to determine whether a telehealth-delivered, geriatric assessment-guided supportive care program (GAIN-S) can improve health outcomes in older adults (age 65 and above) with solid tumors who are starting a new cancer treatment in Brazil. The main questions it aims to answer are: * Does GAIN-S improve physical function, as measured by activities of daily living (ADL), after three months? * Does GAIN-S reduce symptoms of depression and improve quality of life after three months? Researchers will compare patients receiving the GAIN-S intervention to those receiving standard care to see if the intervention leads to better physical function, fewer symptoms of depression, and improved quality of life. Participants will: * Complete a geriatric assessment (CARG-GA) before and after treatment. * Be randomized to either standard care or the GAIN-S intervention. * If assigned to GAIN-S, receive tailored supportive care via telehealth, which may include consultations with a psychologist, psychiatrist, nutritionist, geriatrician, exercise physiologist, or other specialists based on their needs.

Detailed description

This is a multicenter, randomized controlled trial evaluating the effectiveness of a telehealth-delivered, geriatric assessment-guided intervention (GAIN-S) in improving health outcomes for older adults with solid tumors who are initiating a new systemic cancer therapy (chemotherapy, immune checkpoint inhibitors, and/or tyrosine kinase inhibitors) in Brazil. The intervention is adapted from the Geriatric Assessment and Intervention Network (GAIN) model and integrates multidisciplinary supportive care services delivered remotely. The study is conducted across 14 oncology practices, including both private and public institutions, located in the Midwest, South, Southwest, and North regions of Brazil. A total of 350 participants aged 65 years and older will be enrolled and randomized 1:1 to either the GAIN-S intervention or standard of care (SOC). All participants will complete a validated geriatric assessment (CARG-GA) at baseline and again at 3 months. The CARG-GA evaluates functional status, comorbidities, psychological well-being, nutrition, cognitive status, social support, and fall risk. In the intervention arm (GAIN-S), patients will receive a tailored set of supportive care services based on their GA results. The multidisciplinary team-consisting of a medical oncologist, geriatrician, psychologist, psychiatrist, nutritionist, and exercise physiologist-will review the GA findings and deliver recommendations via telehealth (e.g., video calls or phone). Patients may receive one or more remote consultations from team members depending on their individual needs. In the SOC arm, GA results will be shared with the treating oncologist, but no structured intervention will be implemented unless a critical issue is identified (e.g., severe depression or cognitive impairment), in which case referrals may be made. The primary outcome is change in physical function (Activities of Daily Living - ADL) from baseline to 3 months. Secondary outcomes include changes in depression symptoms (Geriatric Depression Scale - GDS) and health-related quality of life (FACT-G) from baseline to 3 months. In addition to the main trial, a separate feasibility study will be conducted to evaluate the implementation of the GAIN-S intervention in public hospital settings. This feasibility study will recruit 50 patients from public hospitals in Brazil and will assess the practicality, acceptability, and potential barriers to delivering geriatric telehealth interventions in resource-limited environments. The study aims to address key gaps in cancer care delivery for older adults in low- and middle-income countries, where access to geriatric-trained oncology professionals is limited. The use of telehealth and standardized GA tools seeks to provide a scalable model for personalized care and improve outcomes in this underserved population.

Interventions

OTHERGAIN-S Multidisciplinary Telehealth Intervention

This intervention delivers a comprehensive geriatric assessment (GA) via telehealth to older adults with cancer. Based on the GA results, a multidisciplinary team including oncologists, geriatricians, psychiatrists, psychologists, nutritionists, and certified fitness trainers provide personalized supportive care recommendations and consultations remotely. The goal is to improve physical function, reduce depressive symptoms, and enhance quality of life during cancer treatment.

Participants receive the usual oncology care provided by their treating physicians without a structured geriatric assessment-driven intervention. Geriatric assessment results are shared with the treating oncologist, who may refer patients to supportive care services based on clinical judgment. No coordinated multidisciplinary telehealth intervention is provided.

Sponsors

City of Hope Comprehensive Cancer Center
CollaboratorOTHER
Cristiane Decat Bergerot, PhD
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Masking description

This is an open-label trial because: * Participants know if they are receiving the GAIN-S intervention. * The care providers and multidisciplinary team also know which arm the participant is in. * Masking is not feasible due to the nature of the intervention (telehealth and tailored supportive care).

Intervention model description

This is a multicenter, two-arm, parallel-group randomized controlled trial. Participants are randomized in a 1:1 ratio to receive either a telehealth-delivered, geriatric assessment-guided multidisciplinary intervention (GAIN-S) or standard of care. Randomization is stratified by institution and disease stage (stage I-III vs. IV), using variable block sizes.

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 65 years or older at time of enrollment * Diagnosed with a solid tumor cancer of any stage * Scheduled to start a new systemic cancer therapy (chemotherapy, immune checkpoint inhibitors, and/or tyrosine kinase inhibitors) * Able to provide written informed consent * Physician approval for participation

Exclusion criteria

* Inability or unwillingness to comply with study procedures, including telehealth visits * Cognitive or other impairments precluding participation as determined by the investigator * Any condition that, in the investigator's opinion, would make the patient unsuitable for the study or interfere with study assessments

Design outcomes

Primary

MeasureTime frameDescription
Change in Physical Function (Activities of Daily Living - ADL) ScoreBaseline to 3 months after treatment initiationPhysical function will be assessed by measuring changes in the Activities of Daily Living (ADL) score using the patient-reported portion of the CARG-GA. The primary objective is to determine if the GAIN-S intervention improves physical function compared to standard care.

Secondary

MeasureTime frameDescription
Change in Symptoms of Depression (Geriatric Depression Scale - GDS)Baseline to 3 months after treatment initiationDepressive symptoms will be measured using the Geriatric Depression Scale (GDS). The study aims to evaluate whether the GAIN-S intervention reduces symptoms of depression compared to standard care.
Change in Health-Related Quality of Life (FACT-G Score)Baseline to 3 months after treatment initiationQuality of life will be measured by the Functional Assessment of Cancer Therapy - General (FACT-G) questionnaire. The study will assess if the intervention stabilizes or improves quality of life compared to standard care.

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 29, 2026